Vasoactive Intestinal Peptide-Secreting Tumors: A Review

Pradeep Kumar Siddappa, Santhi Swaroop Vege

Research output: Contribution to journalArticle

Abstract

Vasoactive intestinal peptide-secreting tumors (VIPomas) are a group of rare neuroendocrine tumors, which cause a typical syndrome of watery diarrhea. Most of these tumors are found in the pancreas and are usually detected at a later stage. Although curative resection is not possible in most of these tumors, both symptom and tumor control can be achieved by a multidimensional approach, to enable a long survival of most patients. There are no clear-cut guidelines for the management of VIPomas because of the rarity of this neoplasm and lack of prospective data. In this review, we discuss the available evidence on the clinical features and management of these rare tumors.

Original languageEnglish (US)
Pages (from-to)1119-1125
Number of pages7
JournalPancreas
Volume48
Issue number9
DOIs
StatePublished - Oct 1 2019

Fingerprint

Vipoma
Neoplasms
Neuroendocrine Tumors
Pancreas
Guidelines
Survival

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Vasoactive Intestinal Peptide-Secreting Tumors : A Review. / Siddappa, Pradeep Kumar; Vege, Santhi Swaroop.

In: Pancreas, Vol. 48, No. 9, 01.10.2019, p. 1119-1125.

Research output: Contribution to journalArticle

Siddappa, Pradeep Kumar ; Vege, Santhi Swaroop. / Vasoactive Intestinal Peptide-Secreting Tumors : A Review. In: Pancreas. 2019 ; Vol. 48, No. 9. pp. 1119-1125.
@article{0a16018816be4cbcbe6985f8d9d80598,
title = "Vasoactive Intestinal Peptide-Secreting Tumors: A Review",
abstract = "Vasoactive intestinal peptide-secreting tumors (VIPomas) are a group of rare neuroendocrine tumors, which cause a typical syndrome of watery diarrhea. Most of these tumors are found in the pancreas and are usually detected at a later stage. Although curative resection is not possible in most of these tumors, both symptom and tumor control can be achieved by a multidimensional approach, to enable a long survival of most patients. There are no clear-cut guidelines for the management of VIPomas because of the rarity of this neoplasm and lack of prospective data. In this review, we discuss the available evidence on the clinical features and management of these rare tumors.",
author = "Siddappa, {Pradeep Kumar} and Vege, {Santhi Swaroop}",
year = "2019",
month = "10",
day = "1",
doi = "10.1097/MPA.0000000000001402",
language = "English (US)",
volume = "48",
pages = "1119--1125",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Vasoactive Intestinal Peptide-Secreting Tumors

T2 - A Review

AU - Siddappa, Pradeep Kumar

AU - Vege, Santhi Swaroop

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Vasoactive intestinal peptide-secreting tumors (VIPomas) are a group of rare neuroendocrine tumors, which cause a typical syndrome of watery diarrhea. Most of these tumors are found in the pancreas and are usually detected at a later stage. Although curative resection is not possible in most of these tumors, both symptom and tumor control can be achieved by a multidimensional approach, to enable a long survival of most patients. There are no clear-cut guidelines for the management of VIPomas because of the rarity of this neoplasm and lack of prospective data. In this review, we discuss the available evidence on the clinical features and management of these rare tumors.

AB - Vasoactive intestinal peptide-secreting tumors (VIPomas) are a group of rare neuroendocrine tumors, which cause a typical syndrome of watery diarrhea. Most of these tumors are found in the pancreas and are usually detected at a later stage. Although curative resection is not possible in most of these tumors, both symptom and tumor control can be achieved by a multidimensional approach, to enable a long survival of most patients. There are no clear-cut guidelines for the management of VIPomas because of the rarity of this neoplasm and lack of prospective data. In this review, we discuss the available evidence on the clinical features and management of these rare tumors.

UR - http://www.scopus.com/inward/record.url?scp=85073176732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073176732&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000001402

DO - 10.1097/MPA.0000000000001402

M3 - Article

C2 - 31609932

AN - SCOPUS:85073176732

VL - 48

SP - 1119

EP - 1125

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 9

ER -